听力与言语-语言病理学

行为科学

医学伦理学

你正在浏览Nutrition & Diabetes期刊下所有文献
  • The cannabinoid Δ(9)-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity.

    abstract:BACKGROUND:Cannabinoid type-1 (CB1) receptor inverse agonists improve type 2 diabetes and dyslipidaemia but were discontinued due to adverse psychiatric effects. Δ(9)-Tetrahydrocannabivarin (THCV) is a neutral CB1 antagonist producing hypophagia and body weight reduction in lean mice. We investigated its effects in die...

    journal_title:Nutrition & diabetes

    pub_type: 杂志文章

    doi:10.1038/nutd.2013.9

    authors: Wargent ET,Zaibi MS,Silvestri C,Hislop DC,Stocker CJ,Stott CG,Guy GW,Duncan M,Di Marzo V,Cawthorne MA

    更新日期:2013-05-27 00:00:00

  • Increased vegetable and fruit consumption during weight loss effort correlates with increased weight and fat loss.

    abstract:BACKGROUND:Individuals who focused on calorie counting lost more weight than those who focused on increasing vegetable and fruit (V&F) intake in a weight loss program. We now present serum carotenoid data (biomarkers of V&F intake) from both groups and test whether these biomarkers correlate with changes in weight and ...

    journal_title:Nutrition & diabetes

    pub_type: 杂志文章

    doi:10.1038/nutd.2012.22

    authors: Whigham LD,Valentine AR,Johnson LK,Zhang Z,Atkinson RL,Tanumihardjo SA

    更新日期:2012-10-01 00:00:00

  • Adiponectin gene therapy ameliorates high-fat, high-sucrose diet-induced metabolic perturbations in mice.

    abstract:BACKGROUND AND DESIGN:Adiponectin is an adipokine secreted primarily from adipose tissue that can influence circulating plasma glucose and lipid levels through multiple mechanisms involving a variety of organs. In humans, reduced plasma adiponectin levels induced by obesity are associated with insulin resistance and ty...

    journal_title:Nutrition & diabetes

    pub_type: 杂志文章

    doi:10.1038/nutd.2012.18

    authors: Kandasamy AD,Sung MM,Boisvenue JJ,Barr AJ,Dyck JR

    更新日期:2012-09-10 00:00:00

  • Beyond the fourth wave of genome-wide obesity association studies.

    abstract::Obesity and related complications are major health burdens. Almost 700 million adults are currently obese globally and the prevalence is predicted to rise towards 2030. The sudden change of lifestyle with physical inactivity and excessive calorie intake undoubtedly have a major part of the epidemic development; howeve...

    journal_title:Nutrition & diabetes

    pub_type: 杂志文章

    doi:10.1038/nutd.2012.9

    authors: Sandholt CH,Hansen T,Pedersen O

    更新日期:2012-07-30 00:00:00

  • A proposed potential role for increasing atmospheric CO2 as a promoter of weight gain and obesity.

    abstract::Human obesity has evolved into a global epidemic. Interestingly, a similar trend has been observed in many animal species, although diet composition, food availability and physical activity have essentially remained unchanged. This suggests a common factor-potentially an environmental factor affecting all species. Coi...

    journal_title:Nutrition & diabetes

    pub_type: 杂志文章

    doi:10.1038/nutd.2012.2

    authors: Hersoug LG,Sjödin A,Astrup A

    更新日期:2012-03-05 00:00:00

  • Proximal correlates of metabolic phenotypes during 'at-risk' and 'case' stages of the metabolic disease continuum.

    abstract:OBJECTIVE:To examine the social and behavioural correlates of metabolic phenotypes during 'at-risk' and 'case' stages of the metabolic disease continuum. DESIGN:Cross-sectional study of a random population sample. PARTICIPANTS:A total of 718 community-dwelling adults (57% female), aged 18-92 years from a regional Sou...

    journal_title:Nutrition & diabetes

    pub_type: 杂志文章

    doi:10.1038/nutd.2011.20

    authors: Haren MT,Misan G,Grant JF,Buckley JD,Howe PR,Taylor AW,Newbury J,McDermott RA

    更新日期:2012-01-16 00:00:00

  • Serum adiponectin level is not only decreased in metabolic syndrome but also in borderline metabolic abnormalities.

    abstract:OBJECTIVE:Along with the increasing prevalence of obesity and related diseases, particularly atherosclerotic diseases, metabolic syndrome (MetS) is now a common and major public health issue in many countries around the world. Adiponectin, a protein secreted by the adipose tissue, has become recognized as a key player ...

    journal_title:Nutrition & diabetes

    pub_type: 杂志文章

    doi:10.1038/nutd.2011.13

    authors: Baden MY,Yamada Y,Obata Y,Hosakawa Y,Saisho K,Tamba S,Yamamoto K,Umeda M,Furubayashi A,Tsukamoto Y,Matsuzawa Y

    更新日期:2011-10-10 00:00:00

  • Microfibrillar-associated protein 5 is linked with markers of obesity-related extracellular matrix remodeling and inflammation.

    abstract:OBJECTIVE:Microfibrillar-associated protein 5 (MFAP5) is an extracellular matrix (ECM) glycoprotein, which is colocalized with microfibrils in elastin networks. Its function in adipose tissue (AT) is not known. We have recently shown that the expression of MFAP5 is downregulated in AT along with weight reduction (WR) i...

    journal_title:Nutrition & diabetes

    pub_type: 杂志文章

    doi:10.1038/nutd.2011.10

    authors: Vaittinen M,Kolehmainen M,Schwab U,Uusitupa M,Pulkkinen L

    更新日期:2011-08-29 00:00:00

  • The metabolic activity of gut microbiota in obese children is increased compared with normal-weight children and exhibits more exhaustive substrate utilization.

    abstract:OBJECTIVE:The gut microbiota contribute otherwise impossible metabolic functions to the human host. Shifts in the relative proportions of gut microbial communities in adults have been correlated with intestinal disease and have been associated with obesity. The aim of this study was to elucidate differences in gut micr...

    journal_title:Nutrition & diabetes

    pub_type: 杂志文章

    doi:10.1038/nutd.2011.8

    authors: Payne AN,Chassard C,Zimmermann M,Müller P,Stinca S,Lacroix C

    更新日期:2011-07-18 00:00:00

  • Central obesity and smoking are key modifiable risk factors for elevated C-reactive protein in Asian individuals who are not eligible for statin therapy.

    abstract:OBJECTIVE:Statin therapy reduces coronary heart disease (CHD) and mortality in individuals with elevated C-reactive protein (CRP) but low-density lipoprotein cholesterol below the threshold at which statin therapy is recommended. We determined the proportion of individuals with elevated CRP in whom statin therapy was n...

    journal_title:Nutrition & diabetes

    pub_type: 杂志文章

    doi:10.1038/nutd.2011.4

    authors: Khoo CM,Tan M,Wu Y,Wai CH,Subramaniam T,Lee J,Tai ES

    更新日期:2011-05-23 00:00:00

50 条记录 2/2 页 « 12 »